Maven Bio
Developer of a biopharma commercial intelligence platform designed to improve drug approval rates. The company's platform allows stakeholders of all disciplines to evaluate therapeutic opportunities a...
Valuation
—
Share Price
N/A
Total Raised
$3.6M
Last Round
N/A